Private Capital Group, LLC Eli Lilly & CO Transaction History

Private Capital Group, LLC

$133 Million
Q2 2022

A detailed history of Private Capital Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Private Capital Group, LLC holds 1,048 shares of LLY stock, worth $941,208. This represents 0.26% of its overall portfolio holdings.

Number of Shares

1,048

Previous 1,581 33.71%

Holding current value

$941,208

Previous $453,000 24.94%

% of portfolio

0.26%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $148,563 - $174,434	-533 Reduced 33.71%	1,048 $340,000
Q1 2022 Apr 21, 2022	SELL	$234.69 - $291.66 $469 - $583	-2 Reduced 0.13%	1,581 $453,000
Q4 2021 Jan 24, 2022	SELL	$224.85 - $279.04 $11,917 - $14,789	-53 Reduced 3.24%	1,583 $437,000
Q3 2021 Oct 13, 2021	BUY	$221.6 - $272.71 $2,880 - $3,545	13 Added 0.8%	1,636 $378,000
Q2 2021 Jul 26, 2021	BUY	$180.55 - $233.54 $7,583 - $9,808	42 Added 2.66%	1,623 $373,000

Q1 2021 Apr 12, 2021	SELL	$164.32 - $212.72 $315,987 - $409,060	-1,923 Reduced 54.88%	1,581 $295,000
Q4 2020 Jan 26, 2021	SELL	$130.46 - $172.63 $2,348 - $3,107	-18 Reduced 0.51%	3,504 $592,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $1,462 - $1,691	10 Added 0.28%	3,522 $521,000
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $23,873 - $28,731	-175 Reduced 4.75%	3,512 $577,000
Q1 2020 May 07, 2020	BUY	$119.05 - $147.35 $8,571 - $10,609	72 Added 1.99%	3,687 $511,000
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $97,938 - $121,305	916 Added 33.94%	3,615 $475,000
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $16,766 - $18,237	157 Added 6.18%	2,699 $302,000
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $110 - $129	-1 Reduced 0.04%	2,542 $217,000
Q1 2019 Apr 26, 2019	SELL	$111.31 - $131.02 $72,351 - $85,163	-650 Reduced 20.36%	2,543 $330,000
Q4 2018 Jan 28, 2019	SELL	$105.9 - $118.64 $99,863 - $111,877	-943 Reduced 22.8%	3,193 $369,000
Q3 2018 Oct 31, 2018	SELL	$85.86 - $107.31 $19,404 - $24,252	-226 Reduced 5.18%	4,136 $443,000
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $26,570 - $30,494	351 Added 8.75%	4,362 $372,000
Q1 2018 May 16, 2018	BUY	$74.21 - $87.6 $131,648 - $155,402	1,774 Added 79.3%	4,011 $310,000
Q4 2017 May 18, 2018	BUY	$81.94 - $87.89 $134,709 - $144,491	1,644 Added 277.23%	2,237 $189,000
Q4 2017 Mar 07, 2018	BUY	$81.94 - $87.89 $48,590 - $52,118	593	593 $18,000

Others Institutions Holding LLY

# of Institutions

3,722

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $853B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.

Account

Private Capital Group, LLC Eli Lilly & CO Transaction History